Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Hormone-Dependent Neoplasms

1-methyl-3-isobutylxanthine has been researched along with Hormone-Dependent Neoplasms in 2 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mayer, RM1
Diamond, EJ1
Hollander, VP1
Cox, ME1
Deeble, PD1
Lakhani, S1
Parsons, SJ1

Other Studies

2 other studies available for 1-methyl-3-isobutylxanthine and Hormone-Dependent Neoplasms

ArticleYear
Hormone, serum, and methylxanthine interactions in the regulation of DNA synthesis in organ-cultured rat mammary tumors.
    Journal of the National Cancer Institute, 1980, Volume: 65, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Culture Techniques; Cycli

1980
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
    Cancer research, 1999, Aug-01, Volume: 59, Issue:15

    Topics: 1-Methyl-3-isobutylxanthine; Adenocarcinoma; Androgens; Biomarkers; Bombesin; Bucladesine; Calcium-C

1999